Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
NO-pravastatin is a derivative of pravastatin (Item No. 10010343) that contains a nitric oxide-releasing moiety.1,2 It induces cGMP formation in PC12 cells (EC50 = 2.3 µM) and inhibits the proliferation of isolated rat aortic smooth muscle cells (IC50 = 2.2 µM).1 NO-pravastatin reduces inducible nitric oxide synthase (iNOS) and COX-2 levels in LPS-stimulated RAW 264.7 cells. NO-pravastatin (48.5 mg/kg) reduces splenocyte adhesion to artery segments isolated from wild-type and ApoE-/- mice.2 It reduces infarct size in a mouse model of myocardial infarction when administered at a dose of 22.4 µmol/kg.3 NO-pravastatin (24-48 mg/kg) reduces platelet consumption, lung vessel occlusion, and mortality in mouse models of platelet pulmonary thromboembolism induced by collagen and epinephrine or U-46619 (Item No. 16450).4
WARNING This product is not for human or veterinary use.
1. .
2. .
3. .
4. .